Floatz logo

Therapeutic Asset Ratings

6,369 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Nivolumab
Stage IV Bladder Cancer AJCC v8
M.D. Anderson Cancer CenterP2B (63)
Obinutuzumab
Indolent B-Cell Non-Hodgkin Lymphoma
Reid Merryman, MDP2B (63)
Obinutuzumab
Lymphoplasmacytic Lymphoma
Emory UniversityP2B (63)
Pembrolizumab
Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research EntitiesP2B (63)
Pembrolizumab
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
Seda S. ToluP2B (63)
Pembrolizumab
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Gallbladder Cancer
Merck Sharp & Dohme LLCP2B (63)
Pembrolizumab
Gallbladder Neoplasms
GV20 TherapeuticsP2B (63)
Pembrolizumab
Hormone-Resistant Prostate Carcinoma
University of Wisconsin, MadisonP2B (63)
Pembrolizumab
Marginal Zone Lymphoma
University of UlmP2B (63)
Pembrolizumab
Microsatellite Instability
Fate TherapeuticsP2B (63)
Pembrolizumab
Microsatellite Stable
NextCure, Inc.P2B (63)
Pembrolizumab
Myxoid Liposarcoma
Valo Therapeutics OyP2B (63)
Pembrolizumab
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Pancreatic Adenocarcinoma
Mayo ClinicP2B (63)
Pembrolizumab
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Mayo ClinicP2B (63)
Pembrolizumab
High Grade B-Cell Lymphoma
Mayo ClinicP2B (63)
Pembrolizumab
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical CenterP2B (63)
Pembrolizumab
Sarcoma
Essen BiotechP2B (63)
Pembrolizumab
Synovial Sarcoma
Valo Therapeutics OyP2B (63)
Retifanlimab
Renal Cell Carcinoma
University of California, San DiegoP2B (63)
ROSOPATAMAB
Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty LimitedP2B (63)
Toripalimab
Cancer
Nanjing Immunophage Biotech Co., LtdP2B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2/3B (63)
Showing 651 to 675 of 6,369 assets
PreviousPage 27 of 255Next